Ultragenyx Pharmaceutical | RARE - Cassa E Equivalenti





Cassa E Equivalenti Cambiamento Data
Acadia Pharmaceuticals USD 956.47M 105.02M 2026-06
Agios Pharmaceuticals USD 99.65M 13.95M 2026-06
Alnylam Pharmaceuticals USD 1.71B 2.46M 2026-06
BioCryst Pharmaceuticals USD 154.97M 16.62M 2026-06
BioMarin Pharmaceutical USD 874M 1.35B 2026-06
Immunic USD 186.63M 171.15M 2026-03
Insmed USD 544.76M 37.42M 2026-06
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
Karyopharm Therapeutics USD 90.85M 30.31M 2026-03
Kyowa Hakko Kirin JPY 218.77B 15.83B 2025-12
MacroGenics USD 113.91M 47.39M 2026-06
Moderna USD 1.72B 185M 2026-06
Neurocrine Biosciences USD 332.4M 65.9M 2026-06
PTC Therapeutics USD 1.05B 215.9M 2026-06
Puma Biotechnology USD 53.52M 1.14M 2025-09
Regeneron Pharmaceuticals USD 2.46B 506.8M 2026-06
Sarepta Therapeutics USD 571.15M 106.7M 2026-06
Ultragenyx Pharmaceutical USD 125M 50M 2026-06
Vertex Pharmaceuticals USD 7.85B 605.7M 2026-06